Bacterial co‐infections with SARS‐CoV‐2

R Mirzaei, P Goodarzi, M Asadi, A Soltani… - IUBMB …, 2020 - Wiley Online Library
The pandemic coronavirus disease 2019 (COVID‐19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS‐CoV‐2), has affected millions of people worldwide. To …

COVID-19 clinical profiles and fatality rates in hospitalized patients reveal case aggravation and selective co-infection by limited gram-negative bacteria

KB Said, A Alsolami, S Moussa, F Alfouzan… - International journal of …, 2022 - mdpi.com
Bacterial co-infections may aggravate COVID-19 disease, and therefore being cognizant of
other pathogens is imperative. We studied the types, frequency, antibiogram, case fatality …

The prevalence and impact of coinfection and superinfection on the severity and outcome of COVID-19 infection: an updated literature review

SA Omoush, JAM Alzyoud - Pathogens, 2022 - mdpi.com
Patients with viral illness are at higher risk of secondary infections—whether bacterial, viral,
or parasitic—that usually lead to a worse prognosis. In the setting of Corona Virus Disease …

[HTML][HTML] Bacterial co-infections and antibiotic resistance in patients with COVID-19

H Mahmoudi - GMS hygiene and infection control, 2020 - ncbi.nlm.nih.gov
Background: Bacterial co-infections are frequently identified in viral respiratory infections
and are significant reasons for morbidity and mortality. Information on the prevalence of …

[HTML][HTML] Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment

HY Wu, PH Chang, KY Chen, IF Lin, WH Hsih… - Journal of Microbiology …, 2022 - Elsevier
Abstracts Coronavirus disease 2019 (COVID-19) emerged as a pandemic that spread
rapidly around the world, causing nearly 500 billion infections and more than 6 million …

[HTML][HTML] Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

BJ Langford, M So, S Raybardhan, V Leung… - Clinical microbiology …, 2020 - Elsevier
Background Bacterial co-pathogens are commonly identified in viral respiratory infections
and are important causes of morbidity and mortality. The prevalence of bacterial infection in …

[HTML][HTML] Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

CC Lai, CY Wang, PR Hsueh - Journal of Microbiology, Immunology and …, 2020 - Elsevier
Co-infection has been reported in patients with severe acute respiratory syndrome (SARS)
and Middle East respiratory syndrome, but there is limited knowledge on co-infection among …

Clinical and etiological analysis of co‐infections and secondary infections in COVID‐19 patients: An observational study

S Chen, Q Zhu, Y Xiao, C Wu, Z Jiang… - The Clinical …, 2021 - Wiley Online Library
Background Co‐infections, secondary bacterial or fungal infections, are important risk
factors for poor outcomes in viral infections. The prevalence of co‐infection and secondary …

Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis

MN Hoque, S Akter, ID Mishu, MR Islam… - Microbial …, 2021 - Elsevier
The novel coronavirus infectious disease-2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has traumatized the whole world with the …

The role of co-infections and secondary infections in patients with COVID-19

C Feldman, R Anderson - Pneumonia, 2021 - Springer
Background It has been recognised for a considerable time-period, that viral respiratory
infections predispose patients to bacterial infections, and that these co-infections have a …